Company intelligence / Profile preview

Scigen Pharms

Hauppauge, New York, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

SciGen Pharmaceuticals is a generic pharmaceutical company based in Hauppauge, New York, specializing in the development, manufacturing, and oral solid dose production of high-quality generic medicines. The company operates a state-of-the-art manufacturing facility that provides contract development and manufacturing services (CDMO) to global partners. SciGen focuses on a diverse portfolio of therapeutic areas, including cardiovascular health, central nervous system disorders, and metabolic diseases. By leveraging its integrated R&D and manufacturing capabilities, the company aims to provide affordable and accessible healthcare solutions to the US market.

Therapeutic areas: EndocrinologyCardiovascularNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Scigen Pharms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scigen Pharms.

Explore the full profile